PBYI - PUMA BIOTECHNOLOGY, INC.
IEX Last Trade
3.135
-0.025 -0.797%
Share volume: 15,936
Last Updated: Thu 26 Dec 2024 08:29:57 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$3.16
-0.03
-0.79%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-03-02 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-29 | 2024-05-02 | 2024-08-01 | |
| Total revenue | 57.102 M | 65.675 M | 52.775 M | 54.568 M | 56.116 M | 72.178 M | 43.766 M | 47.083 M | |
| Cost of revenue | 12.495 M | 16.836 M | 13.218 M | 11.857 M | 13.284 M | 24.323 M | 10.728 M | 10.658 M | |
| Gross profit | 44.607 M | 48.839 M | 39.557 M | 42.711 M | 42.832 M | 47.855 M | 33.038 M | 36.425 M | |
| 9.49% | -19.01% | 7.97% | 0.28% | 11.73% | -30.96% | 10.25% | |||
| Operating expenses | 35.214 M | 38.823 M | 35.192 M | 37.819 M | 34.247 M | 33.057 M | 35.337 M | 38.604 M | |
| Selling general and admin | 23.961 M | 25.039 M | 22.486 M | 24.462 M | 22.801 M | 20.184 M | 21.750 M | 24.972 M | |
| Research and development | 11.253 M | 13.784 M | 12.706 M | 13.357 M | 11.446 M | 12.873 M | 13.587 M | 13.632 M | |
| Total expenses | 47.709 M | 55.659 M | 48.410 M | 49.676 M | 47.531 M | 57.380 M | 46.065 M | 49.262 M | |
| 16.66% | -13.02% | 2.62% | -4.32% | 20.72% | -19.72% | 6.94% | |||
| Operating income | 9.393 M | 10.016 M | 4.365 M | 4.892 M | 8.585 M | 14.798 M | -2.299 M | -2.179 M | |
| Ebit | 9.393 M | 10.016 M | 4.365 M | 4.892 M | 8.585 M | 14.798 M | -2.299 M | -2.179 M | |
| Pretax income | -293.000 K | -5.312 M | 1.548 M | 2.313 M | 6.009 M | 12.804 M | -4.595 M | -4.151 M | |
| 1,712.97% | -129.14% | 49.42% | 159.79% | 113.08% | -135.89% | -9.66% | |||
| Income tax | 67.000 K | 294.000 K | 147.000 K | 187.000 K | 213.000 K | 536.000 K | 220.000 K | 378.000 K | |
| Net income basic | -360.000 K | -5.606 M | 1.401 M | 2.126 M | 5.796 M | 12.268 M | -4.815 M | -4.529 M | |
| -1,457.22% | 124.99% | 51.75% | 172.62% | 111.66% | -139.25% | 5.94% | |||
| Net income | -360.000 K | -5.606 M | 1.401 M | 2.126 M | 5.796 M | 12.268 M | -4.815 M | -4.529 M | |
| -1,457.22% | 124.99% | 51.75% | 172.62% | 111.66% | -139.25% | 5.94% |